ANNAW
AleAnna, Inc. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-1.59
52W High
$1.28
52W Low
$0.12
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
15.80%
Forward P/E
—
PEG Ratio
—
About AleAnna, Inc. Warrant
AleAnna, Inc. Warrant (ANNAW) is a dynamic biopharmaceutical company dedicated to developing pioneering therapies to meet significant unmet medical needs. Leveraging cutting-edge technologies, AleAnna focuses on research and clinical development, boasting a promising pipeline of unique drug candidates aimed at improving patient outcomes. Through strategic collaborations within the healthcare sector, the company is well-positioned to facilitate the successful commercialization of its innovative therapeutics, presenting a compelling opportunity for investors to engage with its growth potential in the biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | $25.04M |
| Gross Profit (TTM) | $18.84M |
| EBITDA | $6.10M |
| Operating Margin | 3.81% |
| Return on Equity | 5.32% |
| Return on Assets | 2.06% |
| Revenue/Share (TTM) | $0.62 |
| Book Value | $1.36 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -97.10% |
| Quarterly Revenue Growth (YoY) | 1084.00% |
| Shares Outstanding | 0 |
| Float | $9.29M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/5/2026